Sign In Contact Us
Act with Confidence

2012 CRO Quality Benchmarking - Phase II/III Service Providers

A report on clinical outsourcing and CRO evaluation / selection

Q1, 2012

Please Note: This report is updated annually and the "2013 CRO Quality Benchmarking Report - Phase II/III Service Providers"is now available.

In it's fourth year, the 2012 CRO Quality Benchmarking report has become the cornerstone of ISR's report library. In this year's report, ISR has interviewed 125 individuals from 72 pharmaceutical and biotechnology companies to provide the industry with leading edge insight into Phase II/III clinical outsourcing trends and 352 service assessments of Phase II/III clinical research organizations (CROs).

The report includes service quality evaluations for 25 service providers (14 of which received full profiles) by measuring past experiences across 21 critically important capabilities that affect provider selection and delivery quality.

This year's report contains 234 pages, including hundreds of charts and graphs and in-depth analysis providing the industry with a "Consumer Reports"-style guide to buying and delivering quality product development services. Download our free Report Preview for sample report pages and the full table of contents.

For buyers of clinical research service, this report offers insight into CRO service quality and empowers you to make smarter clinical outsourcing decisions by providing evaluation and selection tools.

For clinical service providers, this critical report offers you insight into your service quality, your competitors' quality, buyers' needs, CRO selection criteria, paths to differentiation, and clinical outsourcing trends and forecasts.

Report Sections

The report includes the following five major sections:

1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions

2. Service Provider Scorecards

3. Segment Selection Rubrics & CROs to Shortlist

4. Service Quality Drill-downs

5. Appendix of Charts and Graphs

Clinical Research Organizations included:

(Companies in BOLD received a full profile)

  • Accenture

  • Aptiv Solutions

  • Bioclinica

  • Charles River

  • Chiltern

  • Cognizant

  • Covance

  • DCRI-Duke

  • Eurofins

  • ICON

  • INC Research (including Kendle)

  • inVentiv (including PharmaNet & i3)

  • Medpace

  • Octagon

  • PAREXEL

  • PPD

  • PRA

  • Premier Research

  • Quintiles

  • RPS

  • SGS Life Sciences

  • Tata

  • Theorem (formerly Omnicare) 

  • UBC

  • Worldwide Clinical Trials

Service quality attributes:

All 14 profiled organizations were measured across 21 service quality attributes critical to clinical development success.

Staff Characteristics

  • Project Manager Quality
  • CRA Quality
  • Therapeutic Expertise
  • Project Team Chemistry
  • Timely Project Communications
  • Minimizing Staff Turnover

Organizational & Financial Characteristics

  • Breadth of Services
  • Global Footprint
  • Low Cost
  • Minimizing Change Orders
  • Overall Value

Operational Excellence

  • Up-front Contingency Planning and Trial Risk Management
  • Speed of Site Start-up
  • Local Market / Regulatory Knowledge
  • Delivery of Clean Data
  • Meeting Schedules and Timelines
  • Meeting Overall Project Timelines
  • Meeting Database Lock Timelines
  • Meeting First Patient - First Visit Timelines
  • Speed of Patient Recruitment
  • Speed of Sites / Investigator Recruitment

We encourage you to download our free Report Preview for sample report pages and the full table of contents.

Similar Reports:

Readers of this report also purchased:

In the News:

03/01/2012 - MedCity News - "INC Research tops CRO quality ranking as M&A shapes pharma outsourcing"